1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Anti-Infective Drug News NOVEMBER 2016

Anti-Infective Drug News NOVEMBER 2016

  • November 2016
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Phase III Success Will Allow Gilead To Expand HCV Franchise
Industry Trend Analysis - Zinplava Approval Will Spur Interest In Antibiotic Companion Therapies
Industry Brief - CDC Advisory Committee Recommends New Dosing Schedule For Trumenba
Industry Brief - Fimbrion/GSK To Co-Develop Novel Antibacterial Therapy For UTIs
Industry Trend Analysis - US Launch Will Allow PaxVax To Target Global Expansion
Industry Brief - Pfizer's Prevenar 13 Granted CFDA Approval For Use In Infants And Children In China
Industry Trend Analysis - Early Results Suggest Outcome Edge For Debio 1450
Industry Trend Analysis - Blockbuster Potential Persists For Solithromycin Despite Narrow Affirmation
Industry Brief - IDMC Recommends To Continue Atox Bio's AB103 Phase III NSTI Study
Industry Brief - RedHill Concludes Positive FDA Type B Meeting On RHB-105 Phase III H. Pylori Study
Industry Brief - DSMB Recommends Viaskin rPT 50mcg For Second Subject Cohort In Phase I Trial
Industry Brief - IDRI Receives Funding From Lilly To Support TB Drug Discovery
Industry Brief - Ajanta Launches New Generics
Industry Brief - Basilea Launched Cresemba In France
Industry Brief - Amplyx' APX001 Granted FDA ODD For Multiple Invasive Fungal/Mold Infections
Industry Brief - Sanofi Enters Collaboration On Zika Vaccine Research
Industry Trend Analysis - GSK HPV Withdrawal Opens Opportunity For Merck
Industry Brief - GSK Seeks FDA Approval For Shingrix To Prevent Shingles
Industry Brief - PharmaJet/Vaccibody Enter Research Collaboration
Industry Brief - Flublok Now Available In Mexico
Industry Brief - Rapiacta IV Drip Infusion Bag Launched In Taiwan To Treat Influenza Type A/B
Industry Brief - Artes/BioSun To Co-Develop HPV Vaccine In Iran
Industry Brief - NACI Issues Grade A Recommendation For Prevnar 13
Industry Brief - UK Researchers Awarded Grant To Develop Novel Vaccines For Epidemic Diseases
Industry Brief - Yisheng Biopharma Enters Collaboration To Develop Next-Generation Of AIDS Vaccine
Industry Trend Analysis - Resistant Strain Demand Will Allow Ibalizumab To Find HIV Niche
Industry Brief - Bayer To Evaluate Nifurtimox Paediatric Formulation In Phase III Chagas Disease Study
Industry Brief - Avidea In-Licenses PolyMAP Technology From PsiOxus
Industry Brief - TaiGen/HEC To Establish New Company For Treatment Of HCV In China
Industry Brief - BIKEN/MTP Enter Deal To Establish Joint Venture
Industry Brief - EnBiotix Acquires Anti-Microbial Peptide Portfolio From AMP
Industry Brief - NeuroVive/Arbutus Terminate Licensing Deal For NVP018
Industry Trend Analysis - HCV Report Will Increase Pressure On Originator Companies To Respond
Industry Trend Analysis - Prodrug HBV Approval Will Lessen HCV Competition Losses For Gilead
Industry Brief - CHMP Recommends Marketing Authorisation Of Vemlidy To Treat HBV Infection
Industry Trend Analysis - Heplisav-B Delay Will Drive Search For New Partners

Table Of Contents

Anti-Infective Drug News NOVEMBER 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

This cancer vaccines report by BCC Research explores present and future strategies within the market which includes prophylactic vaccines and therapeutic vaccines. Use this report to: - Analyze the global ...

Veterinary Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Veterinary Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • August 2016
  • by Transparency Market Research

Veterinary vaccines are extensively used in the prevention of life-threatening animal diseases. This report on the global veterinary vaccines market analyzes the current and future prospects of the market. ...

Vaccines Market by Technology, Disease Indication, End User & Type - Forecasts to 2021

Vaccines Market by Technology, Disease Indication, End User & Type - Forecasts to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The vaccines market is expected to reach USD 48.03 billion by 2021 from USD 32.24 billion in 2016 at a CAGR of 8.3%. The global vaccines market is segmented based on technology, type, disease indication, ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.